Drug discovery

Disease Area Drug discovery

Transgenic Drug Discovery

| Stephanie Vine

A breakthrough in transgenic mice opens the door to “Humabodies.”

Research Field Clinical trials

A Rare Opportunity for Change

| Maryam Mahdi

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.

Disease Area Drug discovery

Rejuvenating Alzheimer’s R&D

| Maryam Mahdi

How can we encourage companies to pursue clinical research for CNS disorders?

Research Field Drug discovery

A Model Experiment

| Audrey Dubourg

Harnessing the potential of microphysiological systems to advance drug discovery.

Research Field Drug discovery

Small, But Mighty

| Brent R Stockwell

Small-molecule inhibition of the SARS-CoV-2 viral protease may represent a promising route for therapy

Research Field Drug discovery

Time to Transform (Re)search and Development

| Claudia Wild

The drug development system is broken; the COVID-19 pandemic is an opportunity to take a bold step towards accessible and affordable therapies

Disease Area Infectious diseases

The COVID-19 Pandemic: A Summary

Expert pathologist Fred Plapp offers a summary of the virus causing COVID-19, its effects, and the pandemic’s evolving status

Research Field Cancer

Cancer and the Microbiome

| Ivan Gladwyn-Ng, Alexander Maue

How advanced studies into the microorganisms we harbor could impact cancer prevention, treatment, and prognosis.

Research Field Neurological

Redirecting Cell Fate

| Jonathan James

A chemical cocktail of small molecules shows promise in driving neuro-regeneration.

Disease Area Cancer

Two-pronged Attack on Neuroblastoma

| Jonathan James

How inhibiting both polyamine synthesis (with DFMO) and uptake (with new small molecule AMXT 1501) could delay tumor development.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register